Published in Congenit Heart Dis on April 01, 2008
Treatment of pulmonary arterial hypertension in congenital heart disease in Singapore versus the Netherlands: age exceeds ethnicity in influencing clinical outcome. Neth Heart J (2016) 0.84
Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism. Neth Heart J (2009) 0.76
Size and function of the atria. Int J Cardiovasc Imaging (2008) 0.75
Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation (2013) 3.90
Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J (2007) 3.87
Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol (2011) 3.69
Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J (2008) 2.73
Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest (2007) 2.68
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 2.52
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med (2015) 2.23
Quantification of right ventricular afterload in patients with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol (2006) 2.12
Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol (2008) 1.97
Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart (2013) 1.95
Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients. Chest (2007) 1.74
The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. Eur Heart J (2005) 1.65
Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension. Eur Respir J (2012) 1.55
Correction of phase offset errors in main pulmonary artery flow quantification. J Magn Reson Imaging (2005) 1.51
Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension. Eur Respir J (2013) 1.50
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol (2012) 1.48
Noninvasive imaging for the postoperative assessment of aortic coarctation patients. Chest (2005) 1.46
Cardiac function and position more than 5 years after pneumonectomy. Ann Thorac Surg (2007) 1.44
Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol (2005) 1.43
Right ventricular ejection fraction is better reflected by transverse rather than longitudinal wall motion in pulmonary hypertension. J Cardiovasc Magn Reson (2010) 1.42
Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome. Can J Cardiol (2010) 1.40
Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood. Circulation (2005) 1.40
Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation (2013) 1.35
Exercise testing to estimate survival in pulmonary hypertension. Med Sci Sports Exerc (2008) 1.31
Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension. Circ Heart Fail (2011) 1.30
Effects of epoprostenol on right ventricular hypertrophy and dilatation in pulmonary hypertension. Chest (2004) 1.26
A comparison of noninvasive MRI-based methods of estimating pulmonary artery pressure in pulmonary hypertension. J Magn Reson Imaging (2005) 1.22
Rapid quantification of myocardial fibrosis: a new macro-based automated analysis. Cell Oncol (Dordr) (2011) 1.22
Impaired stroke volume response to exercise in pulmonary arterial hypertension. J Am Coll Cardiol (2006) 1.18
Progressive dilatation of the main pulmonary artery is a characteristic of pulmonary arterial hypertension and is not related to changes in pressure. Chest (2010) 1.18
Right coronary artery flow impairment in patients with pulmonary hypertension. Eur Heart J (2007) 1.13
Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension. Nat Genet (2013) 1.11
Selective diaphragm muscle weakness after contractile inactivity during thoracic surgery. Ann Surg (2011) 1.09
Accurate assessment of load-independent right ventricular systolic function in patients with pulmonary hypertension. J Heart Lung Transplant (2012) 1.08
Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol (2010) 1.07
Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension. Am J Cardiol (2011) 1.07
Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist? Am Heart J (2007) 1.06
Right ventricular oscillatory power is a constant fraction of total power irrespective of pulmonary artery pressure. Am J Respir Crit Care Med (2010) 1.05
Right ventricular failure in idiopathic pulmonary arterial hypertension is associated with inefficient myocardial oxygen utilization. Circ Heart Fail (2011) 1.02
Cardiopulmonary exercise testing reveals onset of disease and response to treatment in a case of heritable pulmonary arterial hypertension. Pulm Circ (2012) 1.00
Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria. Eur Heart J (2011) 1.00
Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart. Am J Physiol Heart Circ Physiol (2009) 1.00
Interventricular septal configuration at mr imaging and pulmonary arterial pressure in pulmonary hypertension. Radiology (2005) 0.98
Early onset of retrograde flow in the main pulmonary artery is a characteristic of pulmonary arterial hypertension. J Magn Reson Imaging (2011) 0.96
Endothelin receptor blockade combined with phosphodiesterase-5 inhibition increases right ventricular mitochondrial capacity in pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol (2009) 0.95
Improved ECG detection of presence and severity of right ventricular pressure load validated with cardiac magnetic resonance imaging. Am J Physiol Heart Circ Physiol (2008) 0.95
Diaphragm muscle fiber weakness in pulmonary hypertension. Am J Respir Crit Care Med (2010) 0.95
Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension. Respiration (2007) 0.94
Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe? Am J Respir Crit Care Med (2012) 0.93
Early changes in rat hearts with developing pulmonary arterial hypertension can be detected with three-dimensional electrocardiography. Am J Physiol Heart Circ Physiol (2007) 0.93
Pulmonary endarterectomy normalizes interventricular dyssynchrony and right ventricular systolic wall stress. J Cardiovasc Magn Reson (2012) 0.91
Proportional Relations Between Systolic, Diastolic and Mean Pulmonary Artery Pressure are Explained by Vascular Properties. Cardiovasc Eng Technol (2010) 0.91
Ventilatory and cardiocirculatory exercise profiles in COPD: the role of pulmonary hypertension. Chest (2012) 0.91
Acute effects of sildenafil on exercise pulmonary hemodynamics and capacity in patients with COPD. Pulm Pharmacol Ther (2008) 0.91
Rapid quantification of myocardial fibrosis: A new macro-based automated analysis. Anal Cell Pathol (Amst) (2010) 0.90
Signs of right ventricular deterioration in clinically stable patients with pulmonary arterial hypertension. Chest (2015) 0.90
Adherence to guidelines in the clinical care for adults with congenital heart disease: the Euro Heart Survey on adult congenital heart disease. Eur Heart J (2006) 0.89
Multiple suspicious lesions detected by autofluorescence bronchoscopy predict malignant development in the bronchial mucosa in high risk patients. Lung Cancer (2003) 0.88
Delayed contrast-enhanced magnetic resonance imaging in pulmonary arterial hypertension. Circulation (2005) 0.87
Determinants of pulmonary perfusion measured by electrical impedance tomography. Eur J Appl Physiol (2004) 0.87
Risk factors for hemoptysis in idiopathic and hereditary pulmonary arterial hypertension. PLoS One (2013) 0.87
ECG monitoring of treatment response in pulmonary arterial hypertension patients. Chest (2008) 0.86
Relation of resting heart rate to prognosis in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol (2009) 0.86
The effects of exercise on right ventricular contractility and right ventricular-arterial coupling in pulmonary hypertension. Am J Respir Crit Care Med (2015) 0.86
Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension. Clin Cardiol (2013) 0.85
Diaphragm weakness in pulmonary arterial hypertension: role of sarcomeric dysfunction. Am J Physiol Lung Cell Mol Physiol (2012) 0.85
Repaired and open atrial septal defects type II in adulthood: an epidemiological study of a large European cohort. Int J Cardiol (2007) 0.85
Predictors of mortality in inoperable chronic thromboembolic pulmonary hypertension. Respir Med (2009) 0.84
Successful treatment of diffuse pulmonary lymphangiomatosis with bevacizumab. Ann Intern Med (2012) 0.84
Non-invasive stroke volume assessment in patients with pulmonary arterial hypertension: left-sided data mandatory. J Cardiovasc Magn Reson (2008) 0.83
Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertension. Int J Rheumatol (2010) 0.83
Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study. Arthritis Res Ther (2011) 0.83